Clinical Trial Update: Evaluating Electrocardiogram (ECG) Abnormalities From Young Adulthood Through Middle Age

View source ↗

Summary

The NHLBI-sponsored study evaluates ECG abnormalities from young adulthood through middle age; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases | Status: COMPLETED